PerfuseCell Cronus A/S: Financial statements 2018
CVR: 31606810
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
PerfuseCell Cronus A/S (CVR 31606810) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 532,018 and a net result of DKK 167,685 compared with DKK 308,579 the year before. That is a decrease of 69.6% compared with the year before. The profit margin was 31.5%. Equity in the 2018 report amounted to DKK 490,591. The solvency ratio was 84.4%.
- Revenue
- DKK 532,018
- Gross Profit
- DKK 271,584
- Profit/Loss
- DKK 167,685
- Equity
- DKK 490,591
- Total Assets
- DKK 581,369
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 532 t. | 272 t. | 168 t. | 491 t. | - |
| 2017 | 1.7 mio. | 310 t. | 309 t. | 323 t. | - |
| 2016 | 0 | 0 | 0 | 14 t. | - |
| 2015 | 0 | 0 | -180 | 14 t. | - |
| 2014 | 0 | 0 | -3 t. | 15 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
PerfuseCell Cronus A/S has published its annual report for 2017. Revenue came to DKK 1,748,331, and the net result was DKK 308,579.
About PerfuseCell Cronus A/S
PerfuseCell Cronus A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2008. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named PerfuseCell A/S and PumpCell A/S. The management consists of Per Stobbe. The board consists of August Kisling Stobbe, Flemming Petersen and Per Stobbe. The company is owned by Stobbe GmbH. In 2025, the company reported a gross profit of DKK 20,467 and a net result of DKK 23,973 compared with DKK 2,216 the year before. Equity in the 2025 report amounted to DKK 1,070,836.